Skip to main content
Erschienen in: Supportive Care in Cancer 12/2023

01.12.2023 | Research

A qualitative exploration of fear of progression in patients with nasopharyngeal carcinoma treated with proton and heavy ion therapy

verfasst von: Mimi Zheng, Shuman Wang, Yu Zhu, Hongwei Wan

Erschienen in: Supportive Care in Cancer | Ausgabe 12/2023

Einloggen, um Zugang zu erhalten

Abstract

Objective

To investigate fear of progression (FOP) in nasopharyngeal carcinoma (NPC) patients treated with proton and heavy ion therapy.

Methods

Thirty NPC patients were selected for face-to-face semistructured interviews through purposive sampling while using the phenomenological approach in qualitative research. The interviews were transcribed, organized, and analyzed by applying Colaizzi’s seven-step analysis.

Results

Seven themes were summarized, namely, illness uncertainty, trapped into insecurity (including four categories: insecurity about the possibility of discrimination, insecurity about the possibility of the inability to tolerate the pain of retreatment, insecurity about the difficulty of retreatment after recurrence, and insecurity of waiting for test results), hopelessness, loss, guilt toward children, enhancing tolerance toward family, and self-emotional comfort.

Conclusion

We found that women with children and patients who experienced their first episode underwent significant FOP. Patients at the postgraduate level and above were more inclined to feel loss. The finding that respondents expressed is intense FOP while waiting for test results, which provides a reference for the analysis of the trajectory of FOP. Health care professions should be cognitively aware the importance of eliminating patients’ uncertainty and insecurity about disease to enhance their positive experience in coping with cancer.
Literatur
1.
Zurück zum Zitat Herschbach P, Dinkel A (2014) Fear of Progression. Recent Results in Cancer Research. fortschritte Der Krebsforschung progrès Dans Les Recherches Sur Le Cancer 197:11–29PubMed Herschbach P, Dinkel A (2014) Fear of Progression. Recent Results in Cancer Research. fortschritte Der Krebsforschung progrès Dans Les Recherches Sur Le Cancer 197:11–29PubMed
2.
Zurück zum Zitat Butow P, Sharpe L, Thewes B et al (2018) Fear of Cancer Recurrence: A Practical Guide for Clinicians. Oncology (Williston Park) 32(1):32–38PubMed Butow P, Sharpe L, Thewes B et al (2018) Fear of Cancer Recurrence: A Practical Guide for Clinicians. Oncology (Williston Park) 32(1):32–38PubMed
3.
Zurück zum Zitat Yan Hu, Zhenqi Lu (2020) Practical oncology nursing. China: Shanghai Science and Technology Press, (in Chinese) Yan Hu, Zhenqi Lu (2020) Practical oncology nursing. China: Shanghai Science and Technology Press, (in Chinese)
4.
Zurück zum Zitat Lee AWM, Ng WT, Chan JYW et al (2019) Management of locally recurrent nasopharyngeal carcinoma. Cancer Treat Rev 79:101890CrossRefPubMed Lee AWM, Ng WT, Chan JYW et al (2019) Management of locally recurrent nasopharyngeal carcinoma. Cancer Treat Rev 79:101890CrossRefPubMed
5.
Zurück zum Zitat Kong L, Wang L, Shen C et al (2016) Salvage Intensity-Modulated Radiation Therapy (IMRT) for Locally Recurrent Nasopharyngeal Cancer after Definitive IMRT: A Novel Scenario of the Modern Era. Sci Rep 6:32883CrossRefPubMedPubMedCentral Kong L, Wang L, Shen C et al (2016) Salvage Intensity-Modulated Radiation Therapy (IMRT) for Locally Recurrent Nasopharyngeal Cancer after Definitive IMRT: A Novel Scenario of the Modern Era. Sci Rep 6:32883CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Li Y, Liu Y, Wei J et al (2019) Analysis of the level of fear of cancer recurrence and factors influencing it in patients with nasopharyngeal carcinoma. Chin J Gen Pract 17(9):1443–1446 (in Chinese) Li Y, Liu Y, Wei J et al (2019) Analysis of the level of fear of cancer recurrence and factors influencing it in patients with nasopharyngeal carcinoma. Chin J Gen Pract 17(9):1443–1446 (in Chinese)
7.
Zurück zum Zitat Thewes B, Lebel S, Seguin Leclair C, Butow P (2016) A qualitative exploration of fear of cancer recurrence (FCR) amongst Australian and Canadian breast cancer survivors. Support Care Cancer 24(5):2269–2276CrossRefPubMed Thewes B, Lebel S, Seguin Leclair C, Butow P (2016) A qualitative exploration of fear of cancer recurrence (FCR) amongst Australian and Canadian breast cancer survivors. Support Care Cancer 24(5):2269–2276CrossRefPubMed
8.
Zurück zum Zitat Cruickshank S, Steel E, Fenlon D et al (2020) Specialist breast cancer nurses' views on implementing a fear of cancer recurrence intervention in practice: a mixed methods study. Support Care Cancer 28(1):201–210CrossRefPubMed Cruickshank S, Steel E, Fenlon D et al (2020) Specialist breast cancer nurses' views on implementing a fear of cancer recurrence intervention in practice: a mixed methods study. Support Care Cancer 28(1):201–210CrossRefPubMed
9.
Zurück zum Zitat Mutsaers B, Jones G, Rutkowski N et al (2016) When fear of cancer recurrence becomes a clinical issue: a qualitative analysis of features associated with clinical fear of cancer recurrence. Support Care Cancer 24(10):4207–4218CrossRefPubMed Mutsaers B, Jones G, Rutkowski N et al (2016) When fear of cancer recurrence becomes a clinical issue: a qualitative analysis of features associated with clinical fear of cancer recurrence. Support Care Cancer 24(10):4207–4218CrossRefPubMed
10.
Zurück zum Zitat Hall DL, Lennes IT, Pirl WF, Friedman ER, Park ER (2017) Fear of recurrence or progression as a link between somatic symptoms and perceived stress among cancer survivors. Support Care Cancer 25(5):1401–1407CrossRefPubMed Hall DL, Lennes IT, Pirl WF, Friedman ER, Park ER (2017) Fear of recurrence or progression as a link between somatic symptoms and perceived stress among cancer survivors. Support Care Cancer 25(5):1401–1407CrossRefPubMed
11.
Zurück zum Zitat Zomerdijk N, Jongenelis M, Short CE et al (2021) Prevalence and correlates of psychological distress, unmet supportive care needs, and fear of cancer recurrence among haematological cancer patients during the COVID-19 pandemic. Support Care Cancer 29(12):7755–7764CrossRefPubMedPubMedCentral Zomerdijk N, Jongenelis M, Short CE et al (2021) Prevalence and correlates of psychological distress, unmet supportive care needs, and fear of cancer recurrence among haematological cancer patients during the COVID-19 pandemic. Support Care Cancer 29(12):7755–7764CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Hu J, Huang Q, Gao J et al (2021) Mixed Photon and Carbon-Ion Beam Radiotherapy in the Management of Non-Metastatic Nasopharyngeal Carcinoma. Front Oncol 11:653050CrossRefPubMedPubMedCentral Hu J, Huang Q, Gao J et al (2021) Mixed Photon and Carbon-Ion Beam Radiotherapy in the Management of Non-Metastatic Nasopharyngeal Carcinoma. Front Oncol 11:653050CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Lundkvist J, Ekman M, Ericsson SR, Jönsson B, Glimelius B (2005) Proton therapy of cancer: potential clinical advantages and cost-effectiveness. Acta Oncol 44(8):850–861CrossRefPubMed Lundkvist J, Ekman M, Ericsson SR, Jönsson B, Glimelius B (2005) Proton therapy of cancer: potential clinical advantages and cost-effectiveness. Acta Oncol 44(8):850–861CrossRefPubMed
17.
Zurück zum Zitat Edward KL, Welch T (2011) The extension of Colaizzi's method of phenomenological enquiry. Contemp Nurse 39(2):163–171PubMed Edward KL, Welch T (2011) The extension of Colaizzi's method of phenomenological enquiry. Contemp Nurse 39(2):163–171PubMed
18.
Zurück zum Zitat Simard S, Savard J (2015) Screening and comorbidity of clinical levels of fear of cancer recurrence. J Cancer Surviv 9(3):481–491CrossRefPubMed Simard S, Savard J (2015) Screening and comorbidity of clinical levels of fear of cancer recurrence. J Cancer Surviv 9(3):481–491CrossRefPubMed
19.
Zurück zum Zitat Yu Z, Sun D, Sun J (2022) Social Support and Fear of Cancer Recurrence Among Chinese Breast Cancer Survivors: The Mediation Role of Illness Uncertainty. Front Psychol 13:864129CrossRefPubMedPubMedCentral Yu Z, Sun D, Sun J (2022) Social Support and Fear of Cancer Recurrence Among Chinese Breast Cancer Survivors: The Mediation Role of Illness Uncertainty. Front Psychol 13:864129CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Zhang X, Sun D, Wang Z, Qin N (2022) Triggers and Coping Strategies for Fear of Cancer Recurrence in Cancer Survivors: A Qualitative Study. Curr Oncol 29(12):9501–9510CrossRefPubMedPubMedCentral Zhang X, Sun D, Wang Z, Qin N (2022) Triggers and Coping Strategies for Fear of Cancer Recurrence in Cancer Survivors: A Qualitative Study. Curr Oncol 29(12):9501–9510CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Mishel MH (1988) Uncertainty in Illness. J Nurs Scholarsh 20:4 Mishel MH (1988) Uncertainty in Illness. J Nurs Scholarsh 20:4
22.
Zurück zum Zitat Squiers L, Siddiqui M, Kataria I et al (2021) Perceived, Experienced, and Internalized Cancer Stigma: Perspectives of Cancer Patients and Caregivers in India Squiers L, Siddiqui M, Kataria I et al (2021) Perceived, Experienced, and Internalized Cancer Stigma: Perspectives of Cancer Patients and Caregivers in India
23.
Zurück zum Zitat Chen Y, Zhao Y, Yang X et al (2022) USP44 regulates irradiation-induced DNA double-strand break repair and suppresses tumorigenesis in nasopharyngeal carcinoma. Nat Commun 13(1):501CrossRefPubMedPubMedCentral Chen Y, Zhao Y, Yang X et al (2022) USP44 regulates irradiation-induced DNA double-strand break repair and suppresses tumorigenesis in nasopharyngeal carcinoma. Nat Commun 13(1):501CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Shen Y, Qing W, Li Z, Liu G, Shen A (2017) Analysis of symptom clusters and factors influencing the late phase of simultaneous radiotherapy in patients with nasopharyngeal carcinoma. J Nurs Educ 32(14):1279–1284 (in Chinese) Shen Y, Qing W, Li Z, Liu G, Shen A (2017) Analysis of symptom clusters and factors influencing the late phase of simultaneous radiotherapy in patients with nasopharyngeal carcinoma. J Nurs Educ 32(14):1279–1284 (in Chinese)
25.
Zurück zum Zitat Simard S, Thewes B, Humphris G et al (2013) Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv 7(3):300–322CrossRefPubMed Simard S, Thewes B, Humphris G et al (2013) Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv 7(3):300–322CrossRefPubMed
26.
Zurück zum Zitat Kurt S, Altan SN (2022) Correlation of self-efficacy and symptom control in cancer patients. Support Care Cancer 30(7):5849–5857CrossRefPubMed Kurt S, Altan SN (2022) Correlation of self-efficacy and symptom control in cancer patients. Support Care Cancer 30(7):5849–5857CrossRefPubMed
27.
Zurück zum Zitat Kong F, Zhou J, Du C et al (2018) Long-term survival and late complications of intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma. BMC Cancer 18(1):1139CrossRefPubMedPubMedCentral Kong F, Zhou J, Du C et al (2018) Long-term survival and late complications of intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma. BMC Cancer 18(1):1139CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Ng WT, Ngan R, Kwong D et al (2018) Prospective, Multicenter, Phase 2 Trial of Induction Chemotherapy Followed by Bio-Chemoradiotherapy for Locally Advanced Recurrent Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys 100(3):630–638CrossRefPubMed Ng WT, Ngan R, Kwong D et al (2018) Prospective, Multicenter, Phase 2 Trial of Induction Chemotherapy Followed by Bio-Chemoradiotherapy for Locally Advanced Recurrent Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys 100(3):630–638CrossRefPubMed
29.
Zurück zum Zitat McGinty HL, Small BJ, Laronga C, Jacobsen PB (2016) Predictors and patterns of fear of cancer recurrence in breast cancer survivors. Health Psychol 35(1):1–9CrossRefPubMed McGinty HL, Small BJ, Laronga C, Jacobsen PB (2016) Predictors and patterns of fear of cancer recurrence in breast cancer survivors. Health Psychol 35(1):1–9CrossRefPubMed
Metadaten
Titel
A qualitative exploration of fear of progression in patients with nasopharyngeal carcinoma treated with proton and heavy ion therapy
verfasst von
Mimi Zheng
Shuman Wang
Yu Zhu
Hongwei Wan
Publikationsdatum
01.12.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 12/2023
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-023-08028-3

Weitere Artikel der Ausgabe 12/2023

Supportive Care in Cancer 12/2023 Zur Ausgabe

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gut molekulare Response, aber seltener ernste Nebenwirkungen.

Brustkrebs-Prävention wird neu gedacht

04.06.2024 ASCO 2024 Kongressbericht

Zurzeit untersuchen Forschende verschiedene neue Ansätze zur Prävention von Brustkrebs bei Personen mit hohem Risiko. Darunter Denosumab, die prophylaktische Bestrahlung der Brust – und Impfungen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.